MUDr. Markéta Bednaříková, Ph.D.
Assistant professor, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 8280, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 57
2024
-
MISMATCH-REPAIR DEFICIENCY IS ASSOCIATED WITH A HIGHER RISK OF RECURRENCE THAN NO SPECIFIC MOLECULAR PROFILE IN EARLY-STAGE ENDOMETRIAL CANCER
Year: 2024, type: Conference abstract
-
Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer
Journal of Extracellular Vesicles, year: 2024, volume: 13, edition: 3, DOI
2023
-
Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic
Year: 2023, type: Conference abstract
-
Molekulární testování karcinomu endometria - analýza prvních zkušeností z klinické praxe
Klinická onkologie, year: 2023, volume: 36, edition: 3, DOI
-
Novinky v systémové léčbě karcinomu endometria
Year: 2023, type: Article in Periodical (without peer review)
-
Příznivý účinek multimodálního léčebného přístupu u pacientky s primárně pokročilým karcinomem endometria – kazuistika
Year: 2023, type: Article in Periodical (without peer review)
-
THE COMBINED GENOMIC AND IMMUNOHISTOCHEMICAL TUMOR PROFILING AS A TOOL OF PRECISION ONCOLOGY APPROACH IN THE REAL-WORLD COHORT OF PATIENTS WITH GYNECOLOGICAL CANCERS
Year: 2023, type: Conference abstract
-
The role of clonal hematopoiesis variants in the development of myeloid neoplasms post cytotoxic therapy - case series.
Year: 2023, type: Conference abstract
-
Význam nového prediktivního markeru Schlafen 11 u pacientek s karcinomem ovaria léčených chemoterapií založené na platinovém derivátu – výsledky pilotní analýzy
Klinická onkologie, year: 2023, volume: 36, edition: Suppl 1, DOI
2022
-
2022-RA-1304-ESGO Molecular testing of endometrial carcinoma brings growing opportunity to identify patients with inherited risk of cancer
Year: 2022, type: Conference abstract